Patients can access meds and labs in a single visit AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Psoriasis and psoriatic arthritis (PsA) are chronic, immune-mediated inflammatory diseases associated with several shared common comorbidities, of which obesity is one of the most prevalent. A complex ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

The UC Davis Innovation Institute for Food and Health recently hosted scientists, physicians and industry experts to discuss how drugs based on GLP-1 are transforming treatment for obesity, diabetes ...

GLP-1 receptor agonists improve outcomes in patients with coronary plaque and post-STEMI, reducing adverse cardiovascular events and hospitalizations. Patients using GLP-1s show higher event-free ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to hit the market and disrupt the medical sector. These treatments are ...

Thousands of patients are suing over alleged GLP-1 drug injuries. Drugs include Ozempic, Wegovy and Mounjaro.

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

Patients can access meds and labs in a single visit AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay blood testing by Babson Diagnostics, a science-first healthcare technology company trans ...